Home / Health / Sanofi submits new diabetes drug focus to US regulator

Sanofi submits new diabetes drug focus to US regulator


PARIS French drugmaker Sanofi pronounced on Wednesday it had submitted an focus to a U.S. Food and Drug Administration (FDA) for a singular daily insulin injection to provide adults with form 2 diabetes.

Sanofi pronounced it had requested a six-month examination of a new drug focus by a FDA, rather than a customary 10 months.

“A vast unmet medical need still exists for people with form 2 diabetes, as some-more than half are not during their blood sugarine idea notwithstanding regulating verbal drugs or insulin,” Sanofi’s diabetes head, Pierre Chancel, pronounced in a statement.

The latest focus involves a multiple of insulin glargine with a lixisenatide drug, Sanofi said.

(Reporting by James Regan; Editing by Subhranshu Sahu)

Article source: http://www.reuters.com/article/us-sanofi-diabetes-us-idUSKBN0U60I920151223

Scroll To Top